1. Home
  2. AMWL vs CRVS Comparison

AMWL vs CRVS Comparison

Compare AMWL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$4.72

Market Cap

111.4M

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$7.54

Market Cap

634.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
CRVS
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.4M
634.0M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
AMWL
CRVS
Price
$4.72
$7.54
Analyst Decision
Hold
Strong Buy
Analyst Count
7
4
Target Price
$7.58
$13.75
AVG Volume (30 Days)
141.4K
1.6M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$265,023,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.33
N/A
52 Week Low
$3.71
$2.54
52 Week High
$12.95
$9.60

Technical Indicators

Market Signals
Indicator
AMWL
CRVS
Relative Strength Index (RSI) 61.79 37.13
Support Level $3.92 $7.47
Resistance Level $4.86 $9.60
Average True Range (ATR) 0.21 0.54
MACD 0.12 -0.17
Stochastic Oscillator 85.11 3.29

Price Performance

Historical Comparison
AMWL
CRVS

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: